Investigational drug · Phase 2
[StroMed
Not approved by FDA. In 3 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Osteoarthritis.
Phase 2Last checked: Nov 19, 2026Latest source record: Oct 14, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
3
3 still active
All registered trials
n/a
Any phase or sponsor naming "[StroMed"
First trial start
2015
Jul 2015
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "[StroMed", any sponsor or status.
Conditions studied
As listed on its trial records.
- Osteoarthritis
Approved drugs for the same conditions: Osteoarthritis
Largest trials
Live from ClinicalTrials.gov: studies naming "[StroMed" as an intervention, largest first.
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
NCT02844751 · Phase 2 · Recruiting · VivaTech International, Inc. · 4,000 participants · primary completion Aug 2026
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder
NCT02844738 · Phase 2 · Recruiting · VivaTech International, Inc. · 4,000 participants · primary completion Aug 2026
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip
NCT02844764 · Phase 2 · Recruiting · VivaTech International, Inc. · 4,000 participants · primary completion Aug 2026
Newest research
PubMed records naming it or its code names, newest first.
- Management of knee osteoarthritis by combined stromal vascular fraction cell therapy, platelet-rich plasma, and musculoskeletal exercises: a case series.
Gibbs N, Diamond R, Sekyere EO, et al. · J Pain Res 2015
- Migraine and tension-type headache treated with stromal vascular fraction: a case series.
Bright R, Bright M, Bright P, et al. · J Med Case Rep 2014
Also in development for Osteoarthritis
- EloralintideLY3841136Phase 313 trials
Eli Lilly · Obesity, Overweight, Diabetes Mellitus, Type 2
- EtoricoxibPhase 34 trials
Laboratorios Silanes S.A. de C.V. · Gout Arthritis, Gout Attack, Acute Low-back Pain
- RTX-GRT7039Phase 32 trials
Grünenthal GmbH · Osteoarthritis
- mesenchymal stem cellumbilical cord derived MSCsPhase 23 trials
Cell Energy Life Sciences Group Co. LTD · AIDS, Ischemic Heart Disease, Osteoarthritis
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.